e-SPACE Cardio-Renal-Metabolic 2023
Published: 25 March 2023
-
Views:
13270
-
Likes:
7
-
Views:
13270
-
Likes:
7
-
Up Next -
1h 1m 47sPart 2 | Session 9 Plenary session 12 – Managing end-stage disease: focus on QoL
-
58m 8sPart 1 | Session 1 Plenary session 1 – HFpEF Andrew JS Coats, Giuseppe Rosano, Eberhard Standl, María José Soler, Stefan Anker
-
51m 57sPart 1 | Session 2 Satellite symposium – SGLT2 inhibitors in cardio-renal-metabolic patients – the perfect fit? (Supported by an educational grant from the Boehringer Ingelheim & Lilly Alliance) Stefan Anker, Paola Fioretto, Michel Jadoul
-
56m 38sPart 1 | Session 3 Plenary session 2 – SGLT2 updates Andrew JS Coats, Hiddo Lambers Heerspink, Antonio Ceriello, Gianluigi Savarese, Christoph Wanner
-
31m 38sPart 1 | Session 4 Meet the expert – Management of heart failure in real world clinical practice – insights from the REWOLUTION HF surveys Ewa Jankowska, Andrew JS Coats
-
58m 54sPart 1 | Session 5 Plenary session 3 – Weight management in CRM disease Luc Van Gaal, Wolfram Doehner, Milton Packer, Carel le Roux, Tammy Lyn Kindel, Ildiko Lingvay
-
30m 11sPart 1 | Session 6 Meet the expert – Implementation patterns and challenges in HF care: insights from the EVOLUTION HF study (Supported by an educational grant from AstraZeneca) Orly Vardeny, Gianluigi Savarese
-
1h 6m 3sPart 1 | Session 7 Plenary session 4 – Guidelines implementation for acutely ill patients Stephan Von Haehling, Mehriban Isgandar, Alexandre Mebazaa, Adriaan A Voors, Marat Fudim, Vijay Chopra
-
58m 41sPart 1 | Session 8 Plenary session 5 – Mineralocorticoids antagonists in CRM disease Javed Butler, Sunil Bhandari, Edgar V Lerma, Faiez Zannad, Janani Rangaswami, Gerasimos Filippatos
-
25m 15sPart 1 | Session 9 Meet the expert – Single pill combination (SPC) in Cardiorenal metabolic (CRM) disease Stefan Anker, Muthiah Vaduganathan
-
59m 5sPart 1 | Session 10 Plenary session 6 – Diuretics: old drugs, new data, new approaches Nisha Bansal, Christopher Wilcox, Wilfried Mullens, Areef Ishani, William T Abraham
-
1h 20sPart 2 | Session 1 Plenary session 7 – CRM drug management in patients with low eGFR and type 2 diabetes John J Atherton, Petar M Seferovic, John GF Cleland, Michael Böhm, Meg Jardine, Daniël van Raalte
-
43m 41sPart 2 | Session 2 Satellite symposium – Management of CKD without diabetes – SGLT2 inhibitors, the new standard of care (Supported by an educational grant from AstraZeneca) Michel Jadoul, David Wheeler, Pinar Topsever
-
1h 10sPart 2 | Session 3 Plenary session 8 – Diabetes and cardio-renal disease: the relevance of early treatment with the right drug Peter Rossing, Antonio Ceriello, Francesco Prattichizzo, Apostolos G Tsapas, Melanie Davies, John JV McMurray
-
31m 5sPart 2 | Session 4 Meet the expert – Management of hyperkalemia in cardiorenal disease ‒ practical guidance and novel therapeutic options (Supported by an unrestricted educational grant by CSL Vifor) Gianluigi Savarese, Jolanta Małyszko
-
59m 17sPart 2 | Session 5 Plenary session 9 – Managing “metals” Javed Butler, Shelley Zieroth, Iain Macdougall, John GF Cleland, Matthew R Weir, Paola Fioretto
-
41m 30sPart 2 | Session 6 Satellite symposium – Management of hyperkalemia across the cardiorenal spectrum (Supported by an educational grant from AstraZeneca) Matthew R Weir, Andrew JS Coats, Shelley Zieroth, Kieran McCafferty
-
1h 2m 16sPart 2 | Session 7 Plenary session 10 – Management of diabetes with kidney disease Peter Rossing, Sankar Navaneethan, Maria Luiza Caramori, Ian de Boer, Erin D Michos
Overview
e-SPACE Cardio-Renal-Metabolic 2023 was the third edition of the annual global online conference that explores how leading experts, in cardiology, nephrology, and diabetology, are treating the interrelated diseases.
Course leadership Prof Stefan Anker (Berlin, DE), Dr Javed Butler (Texas, US), Prof Antonio Ceriello (Milan, IT), Prof Tara I Chang (California, US), Prof Ian de Boer (Washington, US), Prof Peter Rossing (Copenhagen, DK) and Prof Shelley Zieroth (Winnipeg, CA) lead an interactive programme of plenary sessions, meet the expert, case discussions and satellite symposium sessions focusing on the patient journey.
For the first time, e-SPACE Cardio-Renal-Metabolic 2023 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality, and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease & obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Fausto J Pinto
Professor of Cardiology
Fausto J Pinto, MD, PhD, FESC, FACC, FASE, FSCAI, is a Professor of Cardiology at Lisbon University Medical School and a Senior Consultant at the University Hospital of Santa Maria. He also serves as Director of the Lisbon Cardiovascular Institute. Professor Pinto serves or has served as President of the Association for Research and Development of the Faculty of Medicine (2004–2010), Chairman of the Congress Programme Committee of the European Society of Cardiology (2008–2010), President and Founder of the European Association of Echocardiography (2002–2004), and Councillor of the European Society of Cardiology (2004– 2006). In addition, he serves on the Editorial Board of several international journals and is Editor in Chief of the Portuguese Journal of Cardiology. Professor Pinto graduated from Lisbon University Medical School in 1984 and completed his cardiology fellowship at Santa Maria University Hospital in Lisbon and Stanford University Medical School, where he…
Mitja Lainscak
Professor, Division of Cardiology
Prof Mitja Lainscak is a Professor in the Division of Cardiology at University of Ljubljana, Ljubljana, SI. He is also Director of the Slovenian Research Agency.
A Enrique Caballero
Endocrinologist
Dr A Enrique Caballero is the Faculty Director of International Innovation Programs and Faculty Director of Diabetes Education at Harvard Medical School, Massachusetts, US. He is also an Endocrinologist, Clinical Investigator and Educator.
He is currently the Chair for the Health Care Disparities Committee at the American Diabetes Association (ADA).
His research interests include type 2 diabetes and cardiovascular disease prevention as well as management of diabetes in racial / ethnic minorities.
Cynthia Delgado
Nephrologist
Dr Cynthia Delgado is a Nephrologist at University of California, California, US.
In January 2023 she was the recipient of the National Kidney Foundation (NKF) Garabed Eknoyan Award.
Her interests include addressing the burden of kidney disease and improving life quality of these patients.
Ambarish Pandey
Assistant Professor in Internal Medicine
Dr Ambarish Pandey is an Assistant Professor in Internal Medicine at University of Texas Southwestern Medical Center, Texas, US.
He obtained his medical degree from All India Institute of Medical Sciences, India and fellowship at UT Southwestern Medical Center (2014-2018).
Dr Pandey specialises in preventive cardiology and heart failure with preserved ejection fraction.
He is a member of the American Heart Association (AHA), where he serves on several committees, including the Scientific Sessions Planning Committee and the Epidemiology Early Career Committee.
Comments